Position in ARGX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$593,772
+$189,944 QoQ
Shares Held
640
+15.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#292
of 505 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. ARGX ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
This page
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $593,772 | 640 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $403,828 | 553 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $445,703 | 530 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $438,110 | 594 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $337,897 | 613 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $371,099 | 627 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $415,740 | 676 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $325,248 | 600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $233,511 | 543 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $210,640 | 535 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $149,128 | 392 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $231,557 | 471 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $175,768 | 451 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $163,562 | 439 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $162,896 | 430 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $138,748 | 393 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $127,682 | 337 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $93,331 | 296 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $134,122 | 383 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $40,468 | 134 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $16,558 | 55 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $17,349 | 63 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $7,058 | 24 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,100 | 8 | Shares | Sole | 2020-10-27 | |
| 2020-03-31 | $8,035 | 61 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||